TY - JOUR JO - EuroIntervention TI - A randomised comparison of novolimus-eluting and zotarolimus-eluting coronary stents: 9-month follow-up results of the EXCELLA II study AB - <p class="text-paragraph" xml:lang='fr'><span class="bold">Aims: </span>Novolimus, a macrocyclic lactone with anti-proliferative properties, has a similar efficacy to currently available agents; however it requires a lower dose, and less polymer, and is t AU - Serruys Patrick W. AU - Garg Scot AU - Abizaid A. Alexandre AU - Ormiston A. John AU - Windecker Stephan AU - Verheye Stefan AU - Dubois Christophe AU - Stewart Jim AU - Hauptmann KE AU - Schofer Joachim AU - Stangl Karl AU - Witzenbichler Bernhard AU - Wiemer Marcus AU - Barbato Emanuele AU - de Vries Ton AU - Drijver Anne-Marie AU - Otake Hiromasa AU - Meredith Lynn AU - Toyloy Sara AU - Fitzgerald Peter J. VL - 6 IS - 2 Y1 - 30/06/2010 Y1 - 2010 DOI - SP - 195 EP - 205 KW - novolimus eluting stent KW - zotarolimus eluting stent KW - angioplasty PB - Europa Digital & Publishing SE - Clinical research UR - https://eurointervention.pcronline.com/article/a-randomised-comparison-of-novolimus-eluting-and-zotarolimus-eluting-coronary-stents-9-month-follow-up-results-of-the-excella-ii-study SN - 1774-024X ER -